|
We hope these articles are helpful to you. Please click on the title to read the entire article. Also, please feel free to forward our E-Newsletters to your friends. We would appreciate it greatly if you keep us in mind should you have a friend in need of legal services with an injury claim. Please note that prior Newsletters can be found at our website. Enjoy!
Click here for a Free Initial Evaluation
Or Contact
Us:
jim@adlerandmanson.com
bill@adlerandmanson.com
816.333.0400
Toll Free: 877.336.0400
In
this issue:
Popular Birth Control Pill Draw Fire from Critics
Two of the nation’s top-selling birth control pills may increase the risk of blood clots, strokes and other health problems, some critics charge. According to lawsuits brought against pharmaceutical giant Bayer, the company failed to properly disclose risks associated with the oral contraceptives Yaz and Yasmin. Earlier this year, the Food and Drug Administration ordered Bayer to correct misleading statements made in marketing for Yaz and Yasmin. Natasha Singer, The New York Times 09/25/2009
Facebook Settles Privacy Suit Over Ad System
Facebook has agreed to pay at least $9.5 million to settle a class-action lawsuit over the social networking site’s Beacon advertising system. Facebook users alleged that the site violated privacy laws by publishing video rental histories on the Web. Beacon was launched in 2007 and tracked user activities on non-Facebook sites and then reported them to users' friends, according to the Los Angeles Times. David Sarno, LA Times 09/21/2009
Black Box Warning Ordered for Promethazine
Federal regulators have ordered the makers of injectable promethazine to add the strongest possible warning to the drug. The order from the Food and Drug Administration follows the Supreme Court case of a Vermont musician who lost her arm after being injected with the Wyeth version of the drug Phenergan. Miriam Hill, Philadelphia Inquirer 09/17/2009
Study: Breast Cancer Drugs May Increase Clot Risk
Two
drugs designed to reduce the risk of invasive breast cancer may
increase the risk of women developing serious blood clots, new research
suggests. According to the study, published in the journal Annals of
Internal Medicine, drugs including raloxifene or tamoxifen may
contribute to four to seven additional cases of blood clots among every
1,000 users. Data for the study were collected from eight major medical
trials. Roni Caryn Rabin, The New York Times 09/14/2009
|
